Santa Clara / Zhunan Town / Taipei / Sacramento / Santa Cruz / Denver / Coralville / Mannheim / Cambridge / Melville / Miami / /
Company
Affymetrix Inc. / Dharmacon Inc. / Agilent Technologies / C-TAG Inc. / Sigma-Aldrich / Olympus America Inc. / Leu408 / Abnova Inc. / mCi / Ambion Inc. / Asp538 / Waters Corporation / Cys480 / Santa Cruz Inc. / Cell Signaling Inc. / C-TAG Bioscience Inc / Thr474 / Millipore Inc / Beckman Coulter / IDTDNA Inc. / Chem-Impex International Inc / Merck / Macmillan Publishers Limited / /
Country
United Kingdom / Taiwan / Germany / United States / /
Currency
pence / / /
Event
FDA Phase / /
Facility
Taipei Medical University / Institute of Molecular / University of California Davis / University of California / Shuang Ho Hospital / / /
IndustryTerm
energy / final product / Treatment of PC3 and other prostate cancer / treatment of chronic lymphocytic leukemia / care for metastatic prostate cancer / putative binding site / therapy for prostate cancer / web service / reaction solution / lowest binding free energy / chemical structure / preferred binding site / /
MedicalCondition
metastatic prostate cancer / multiple myeloma / arthritis / prostate cancers / bladder cancer / higher grade tumors / human diseases / frequently diagnosed cancer / prostate cancer / breast cancer / leukemia / cancer metastasis / tumor / In glioblastoma / cancer / nasopharyngeal carcinoma / tumors / agammaglobulinemia / hepatocellular carcinoma / carcinogenesis / PC3 prostate cancer / hematopoietic diseases / Deficiency / hematopoietic malignancies / prostate cancer xenograft tumor / PC3 xenograft tumor / prostate carcinogenesis / lymphoma / chronic lymphocytic leukemia / metastasis / PC3 human prostate cancer / solid tumors / PC3 xenograft tumors / solid cancers / Up To Cancer / Disease / tissues and prostate cancer / androgen-independent tumor / human prostate cancer / prostate cancer cell growth / tumor metastasis / Paraffin-embedded tumor / impotence / /
MedicalTreatment
surgery / chemo / photodynamic therapy / /
Organization
Taipei Medical University / University of California Davis / Sacramento / Institutional Animal Care and Use Committee / Department of Biochemistry and Molecular Medicine / Etk / DOD Postdoctoral Training Award PC080859 and Auburn Community Cancer Endowment Fund / American Association for Cancer Research / Movember Foundation / Shuang Ho Hospital / National Institute of Health / Entertainment Industry Foundation / University of California / Davis / Institute of Molecular and Genomic Medicine / Department of Defense / / /
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor